Thursday, October 25, 2012 4:26:53 PM
Recent QGEN News
- QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- QIAGEN N.V. to release results for Q1 2024 and hold webcast • GlobeNewswire Inc. • 04/09/2024 01:48:45 PM
- QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024 • GlobeNewswire Inc. • 04/03/2024 08:05:00 PM
- QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system • GlobeNewswire Inc. • 03/25/2024 08:05:00 PM
- QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements • GlobeNewswire Inc. • 03/18/2024 08:05:00 PM
- QIAGEN announces Form 20-F annual report filing for 2023 results • GlobeNewswire Inc. • 03/11/2024 09:59:51 AM
- QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery • GlobeNewswire Inc. • 02/27/2024 10:44:59 PM
- QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification • GlobeNewswire Inc. • 02/15/2024 09:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 02:47:31 PM
- QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability • GlobeNewswire Inc. • 02/06/2024 09:05:00 PM
- QIAGEN announces partnership with Penn State University to advance microbiome sciences • GlobeNewswire Inc. • 01/25/2024 03:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:13:55 PM
- QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million • GlobeNewswire Inc. • 01/18/2024 09:05:00 PM
- QIAGEN N.V. to release results for Q4 2023 and hold webcast • GlobeNewswire Inc. • 01/11/2024 12:53:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 02:59:04 PM
- QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems • GlobeNewswire Inc. • 01/08/2024 07:00:00 AM
- QIAGEN announces plans to return approximately $300 million to shareholders • GlobeNewswire Inc. • 01/07/2024 06:07:00 PM
- QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics business • GlobeNewswire Inc. • 01/04/2024 09:05:00 PM
- QIAGEN expands business in Middle East with new regional headquarters and major projects • GlobeNewswire Inc. • 01/03/2024 07:00:00 AM
- DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy • GlobeNewswire Inc. • 11/30/2023 09:05:00 PM
- QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolation • GlobeNewswire Inc. • 11/15/2023 09:05:00 PM
- QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customers • GlobeNewswire Inc. • 11/09/2023 09:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM